Gri Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.39

+0.20 (+9.13%)

As of Feb 8, 2:33 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +1,548.1% upside

Low Target $26.66

Average Target $39.39

High Target $54.88

Current Price $2.39

Current
$2.39

Target
$39.39

$26.66 $39.39 avg $54.88

Scenario Analysis

Bear Case

$26.66

1,015.5%

Low target

Base Case

$39.39

+1,548.1%

Avg target

Bull Case

$54.88

+2,196.2%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$38.68

-93.8% from high

52-Week Low

$26.33

+-90.9% from low

Target vs 52W High

$39.39

+1.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%